Published in Int J Mol Sci on June 28, 2017
Genome-wide analysis of estrogen receptor binding sites. Nat Genet (2006) 18.63
Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell (2009) 18.31
Environmental epigenomics and disease susceptibility. Nat Rev Genet (2007) 11.02
Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57
Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev (1999) 7.06
Host-Pathogen Interactions: IX. Quantitative Assays of Elicitor Activity and Characterization of the Elicitor Present in the Extracellular Medium of Cultures of Phytophthora megasperma var. sojae. Plant Physiol (1976) 6.80
Mechanisms of estrogen action. Physiol Rev (2001) 5.97
Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology (2003) 4.96
Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev (2005) 4.27
Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology (2006) 2.85
Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J Clin Endocrinol Metab (1997) 2.73
Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene (2006) 2.69
Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A (1997) 2.49
Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology (2006) 2.49
Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun (2005) 2.37
The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol (2011) 2.33
Overview of nomenclature of nuclear receptors. Pharmacol Rev (2006) 2.21
Several environmental oestrogens are also anti-androgens. J Endocrinol (1998) 2.17
An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol (1998) 2.13
Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci (2004) 1.92
The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett (2007) 1.90
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J Mol Endocrinol (2008) 1.89
Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res (1998) 1.79
Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr (2003) 1.79
Apigenin: a promising molecule for cancer prevention. Pharm Res (2010) 1.78
Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Mol Endocrinol (2008) 1.70
Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res (2002) 1.67
Lignans and human health. Crit Rev Clin Lab Sci (2007) 1.64
Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environ Health Perspect (2000) 1.63
Integration of the non-genomic and genomic actions of estrogen. Membrane-initiated signaling by steroid to transcription and cell biology. J Biol Chem (2002) 1.60
Equol: history, chemistry, and formation. J Nutr (2010) 1.56
Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am J Clin Nutr (2009) 1.49
Hypermethylation and expression regulation of secreted frizzled-related protein genes in colorectal tumor. World J Gastroenterol (2006) 1.45
Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis (1996) 1.44
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis (2009) 1.44
Developmental exposure to TCDD reduces fertility and negatively affects pregnancy outcomes across multiple generations. Reprod Toxicol (2010) 1.38
What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol Sci (2003) 1.34
Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest. Cell Death Differ (2010) 1.34
Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene (2003) 1.31
The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses. Environ Health Perspect (2003) 1.30
Localization of the human oestrogen receptor gene to chromosome 6q24----q27 by in situ hybridization. Cytogenet Cell Genet (1986) 1.29
Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect (2001) 1.29
Dioxin (TCDD) induces epigenetic transgenerational inheritance of adult onset disease and sperm epimutations. PLoS One (2012) 1.28
Soy isoflavones: a safety review. Nutr Rev (2003) 1.27
Functional Genomic Landscape of Human Breast Cancer Drivers, Vulnerabilities, and Resistance. Cell (2016) 1.26
Resveratrol and breast cancer chemoprevention: molecular mechanisms. Mol Nutr Food Res (2005) 1.25
Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int J Cancer (2011) 1.24
Female sexual maturation and reproduction after prepubertal exposure to estrogens and endocrine disrupting chemicals: a review of rodent and human data. Mol Cell Endocrinol (2006) 1.20
Distinct structural transitions of chromatin topological domains correlate with coordinated hormone-induced gene regulation. Genes Dev (2014) 1.20
Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol (2004) 1.20
Impairment in protein expression profile of testicular steroid receptor coregulators in male rat offspring perinatally exposed to Bisphenol A. Life Sci (2009) 1.19
Endogenous estrogens inhibit mouse fetal Leydig cell development via estrogen receptor alpha. Endocrinology (2005) 1.19
Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon (2001) 1.17
Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer. Mol Cancer (2013) 1.17
Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol (2013) 1.13
Minireview: role of kinases and chromatin remodeling in progesterone signaling to chromatin. Mol Endocrinol (2010) 1.09
Stroke in women: disparities and outcomes. Curr Cardiol Rep (2010) 1.07
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Carcinogenesis (2011) 1.07
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy. BMC Cancer (2008) 1.05
Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy. J Pharmacol Exp Ther (2009) 1.05
Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity. Mol Endocrinol (2012) 1.03
Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells. Cancer Res (2006) 1.01
Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett (1996) 1.00
A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo. Endocrinology (2008) 1.00
Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line. Exp Biol Med (Maywood) (2011) 1.00
Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. Hum Reprod (2001) 0.97
Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Curr Pharm Des (2010) 0.97
The chemopreventive properties of soy isoflavonoids in animal models of breast cancer. Breast Cancer Res Treat (1998) 0.97
Phytoestrogen-mediated inhibition of proliferation of the human T47D breast cancer cells depends on the ERalpha/ERbeta ratio. J Steroid Biochem Mol Biol (2008) 0.96
Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability. Food Chem Toxicol (2000) 0.96
Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. In Vivo (2010) 0.96
Estrogen receptor-alpha gene expression in the cortex: sex differences during development and in adulthood. Horm Behav (2010) 0.95
Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.95
Soy, phytoestrogens and their impact on reproductive health. Mol Cell Endocrinol (2011) 0.95
Genistein affects histone modifications on Dickkopf-related protein 1 (DKK1) gene in SW480 human colon cancer cell line. PLoS One (2012) 0.93
Extranuclear estrogen receptor's roles in physiology: lessons from mouse models. Am J Physiol Endocrinol Metab (2014) 0.93
Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial. Cancer Epidemiol Biomarkers Prev (2004) 0.93
Mechanisms enforcing the estrogen receptor β selectivity of botanical estrogens. FASEB J (2013) 0.92
In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Mol Sci (2015) 0.92
Dietary flavonoids: molecular mechanisms of action as anti- inflammatory agents. Recent Pat Inflamm Allergy Drug Discov (2011) 0.91
Phytoestrogens for hormone replacement therapy? J Steroid Biochem Mol Biol (2002) 0.90
Fusarin C acts like an estrogenic agonist and stimulates breast cancer cells in vitro. Toxicol Lett (2011) 0.90
Estrogen receptor beta is essential for sprouting of nociceptive primary afferents and for morphogenesis and maintenance of the dorsal horn interneurons. Proc Natl Acad Sci U S A (2007) 0.89
Expression of estrogen receptor ESR1 and its 46-kDa variant in the gubernaculum testis. Biol Reprod (2005) 0.88
Environmental effects on hormonal regulation of testicular descent. J Steroid Biochem Mol Biol (2006) 0.87
Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands. Biochem Pharmacol (2011) 0.87
Coumestrol, a new estrogen isolated from forage crops. Science (1957) 0.86
Evaluation of bone quality and quantity in osteoporotic mice--the effects of genistein and equol. Phytomedicine (2009) 0.86
Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation. J Steroid Biochem Mol Biol (2015) 0.85
Anticancer effect of genistein on BG-1 ovarian cancer growth induced by 17 β-estradiol or bisphenol A via the suppression of the crosstalk between estrogen receptor α and insulin-like growth factor-1 receptor signaling pathways. Toxicol Appl Pharmacol (2013) 0.85
Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells. Eur J Nutr (2014) 0.85
Infant feeding with soy formula milk: effects on puberty progression, reproductive function and testicular cell numbers in marmoset monkeys in adulthood. Hum Reprod (2006) 0.85
Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells. Anticancer Res (2014) 0.85
Evidence that low-dose, long-term genistein treatment inhibits oestradiol-stimulated growth in MCF-7 cells by down-regulation of the PI3-kinase/Akt signalling pathway. J Steroid Biochem Mol Biol (2009) 0.84
Genistein induces apoptosis and autophagy in human breast MCF-7 cells by modulating the expression of proapoptotic factors and oxidative stress enzymes. Mol Cell Biochem (2014) 0.84
Expression profiling of the genes responding to zearalenone and its analogues using estrogen-responsive genes. FEBS Lett (2009) 0.84
Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats. Toxicol Appl Pharmacol (2007) 0.84
Coumestrol has neuroprotective effects before and after global cerebral ischemia in female rats. Brain Res (2012) 0.84
Environmental epigenetics and phytoestrogen/phytochemical exposures. J Steroid Biochem Mol Biol (2012) 0.84